Literature DB >> 24041424

Optimization of Tet1 ligand density in HPMA-co-oligolysine copolymers for targeted neuronal gene delivery.

David S H Chu1, Joan G Schellinger, Michael J Bocek, Russell N Johnson, Suzie H Pun.   

Abstract

Targeted gene delivery vectors can enhance cellular specificity and transfection efficiency. We demonstrated previously that conjugation of Tet1, a peptide that binds to the GT1b ganglioside, to polyethylenimine results in preferential transfection of neural progenitor cells in vivo. In this work, we investigate the effect of Tet1 ligand density on gene delivery to neuron-like, differentiated PC-12 cells. A series of statistical, cationic peptide-based polymers containing various amounts (1-5 mol%) of Tet1 were synthesized via one-pot reversible addition-fragmentation chain transfer (RAFT) polymerization by copolymerization of Tet1 and oligo-l-lysine macromonomers with N-(2-hydroxypropyl)methacrylamide (HPMA). When complexed with plasmid DNA, the resulting panel of Tet1-functionalized polymers formed particles with similar particle size as particles formed with untargeted HPMA-oligolysine copolymers. The highest cellular uptake in neuron-like differentiated PC-12 cells was observed using polymers with intermediate Tet1 peptide incorporation. Compared to untargeted polymers, polymers with optimal incorporation of Tet1 increased gene delivery to neuron-like PC-12 cells by over an order of magnitude but had no effect compared to control polymers in transfecting NIH/3T3 control cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HPMA polymer; Neuron delivery; Non-viral gene delivery; Peptide copolymers; Targeted delivery

Mesh:

Substances:

Year:  2013        PMID: 24041424      PMCID: PMC3855292          DOI: 10.1016/j.biomaterials.2013.08.045

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  36 in total

1.  A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting.

Authors:  James K Liu; Qingshan Teng; Mary Garrity-Moses; Thais Federici; Diana Tanase; Michael J Imperiale; Nicholas M Boulis
Journal:  Neurobiol Dis       Date:  2005-08       Impact factor: 5.996

Review 2.  Viral vectors, tools for gene transfer in the nervous system.

Authors:  W T Hermens; J Verhaagen
Journal:  Prog Neurobiol       Date:  1998-07       Impact factor: 11.685

3.  Structure and dynamics of condensed DNA probed by 1,1'-(4,4,8,8-tetramethyl-4,8-diazaundecamethylene)bis[4-[[3- methylbenz-1,3-oxazol-2-yl]methylidine]-1,4-dihydroquinolinium] tetraiodide fluorescence.

Authors:  G Krishnamoorthy; Guy Duportail; Yves Mély
Journal:  Biochemistry       Date:  2002-12-24       Impact factor: 3.162

4.  Rapid analysis of amino acids using pre-column derivatization.

Authors:  B A Bidlingmeyer; S A Cohen; T L Tarvin
Journal:  J Chromatogr       Date:  1984-12-07

5.  A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression.

Authors:  K D Fisher; K Ulbrich; V Subr; C M Ward; V Mautner; D Blakey; L W Seymour
Journal:  Gene Ther       Date:  2000-08       Impact factor: 5.250

6.  The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies.

Authors:  Jin Wang; Shaomin Tian; Robby A Petros; Mary E Napier; Joseph M Desimone
Journal:  J Am Chem Soc       Date:  2010-08-18       Impact factor: 15.419

7.  Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.

Authors:  Christophe Lo Bianco; Bernard L Schneider; Matthias Bauer; Ali Sajadi; Alexis Brice; Takeshi Iwatsubo; Patrick Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

8.  Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.

Authors:  Corinna Burger; Oleg S Gorbatyuk; Margaret J Velardo; Carmen S Peden; Philip Williams; Sergei Zolotukhin; Paul J Reier; Ronald J Mandel; Nicholas Muzyczka
Journal:  Mol Ther       Date:  2004-08       Impact factor: 11.454

9.  Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells.

Authors:  M E Greenberg; L A Greene; E B Ziff
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

10.  Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium.

Authors:  L A Greene
Journal:  J Cell Biol       Date:  1978-09       Impact factor: 10.539

View more
  14 in total

Review 1.  Targeting specific cells in the brain with nanomedicines for CNS therapies.

Authors:  Fan Zhang; Yi-An Lin; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2015-12-11       Impact factor: 9.776

Review 2.  Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

Authors:  Elizabeth S Smith; Joshua E Porterfield; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2019-03-04       Impact factor: 15.470

3.  RNA Delivery via DNA-Inspired Janus Base Nanotubes for Extracellular Matrix Penetration.

Authors:  Ian Sands; Jinhyung Lee; Wuxia Zhang; Yupeng Chen
Journal:  MRS Adv       Date:  2020-01-24

4.  Trigger-responsive, fast-degradable poly(β-amino ester)s for enhanced DNA unpackaging and reduced toxicity.

Authors:  Xiaojian Deng; Nan Zheng; Ziyuan Song; Lichen Yin; Jianjun Cheng
Journal:  Biomaterials       Date:  2014-03-24       Impact factor: 12.479

5.  Experimental study of a nanoscale translocation ratchet.

Authors:  Bastien Molcrette; Léa Chazot-Franguiadakis; François Liénard; Zsombor Balassy; Céline Freton; Christophe Grangeasse; Fabien Montel
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-18       Impact factor: 12.779

Review 6.  Overcoming barriers in non-viral gene delivery for neurological applications.

Authors:  Aaron Tasset; Arjun Bellamkonda; Wenliang Wang; Ilya Pyatnitskiy; Deidra Ward; Nicholas Peppas; Huiliang Wang
Journal:  Nanoscale       Date:  2022-03-10       Impact factor: 8.307

7.  The effect of side-chain functionality and hydrophobicity on the gene delivery capabilities of cationic helical polypeptides.

Authors:  Rujing Zhang; Nan Zheng; Ziyuan Song; Lichen Yin; Jianjun Cheng
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

8.  Reducible, dibromomaleimide-linked polymers for gene delivery.

Authors:  James-Kevin Y Tan; Jennifer L Choi; Hua Wei; Joan G Schellinger; Suzie H Pun
Journal:  Biomater Sci       Date:  2014-08-12       Impact factor: 6.843

Review 9.  Dual Polymerizations: Untapped Potential for Biomaterials.

Authors:  Daniel C Lee; Robert J Lamm; Alex N Prossnitz; Andrew J Boydston; Suzie H Pun
Journal:  Adv Healthc Mater       Date:  2018-10-21       Impact factor: 9.933

10.  Engineering biodegradable and multifunctional peptide-based polymers for gene delivery.

Authors:  Julie Shi; Joan G Schellinger; Suzie H Pun
Journal:  J Biol Eng       Date:  2013-10-24       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.